Diligence memo · auto-generated · as of July 3, 2026
Genome Medical Holding Co
Genome Medical Holding Co looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Genome Medical Holding Co operates in Healthtech, based in South San Francisco.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Genome Medical Holding Co has raised $90M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $75M on 2024-09-10.
Most recent recorded round closed around 2024-09-10.
Valuation (modeled)modeled
Provath models Genome Medical Holding Co at approximately $606M (range $274M–$897M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.25× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era. Within the normal band (125% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 25 months.
Last raise 22 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 5.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 95% of Healthtech peers (2138 compared).
Modeled value ranks above 94% of those peers.
Closest niche peers: Freedom Dental Funding, LLC, Elevate Care International Topco LP, Athelas Inc., Hazel Health, Inc., Health Gorilla, Inc..
Peoplefiled
19 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.